Top Markets
Coin of the day
Coeptis Therapeutics Holdings, Inc. Coeptis Therapeutics Holdings, Inc.

Coeptis Therapeutics Holdings, Inc.

COEP
Classement en actions #28025
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates... Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Prix de l'action
$4.81
Dernière synchronisation: 2026-07-27
Capitalisation boursière
$29.01M
Changement (1 jour)
-8.56%
Changement (1 an)
-64.66%
Pays
US
Échange Coeptis Therapeutics Holdings, Inc. (COEP)

Catégorie

Historique du prix de l'action pour Coeptis Therapeutics Holdings, Inc. (COEP)
Prix de clôture le plus élevé : $6.93 le 2026-07-01

Prix de clôture le plus bas : $201.89 le 2020-12-01
Historique du prix de l'action de Coeptis Therapeutics Holdings, Inc. de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -14.55%
2025 310.00%
2024 -80.37%
2023 -39.69%
2022 -84.27%
2021 -1.07%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.49 -13.75%
AU
$753.28 5.84%
CH